Expression of ABCG2 and its significance in colorectal cancer

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 4, 2010, Pages 845-848

  Liu, Hai Guang ^a   Pan, Yi Fei ^a   You, Jie ^a   Wang, Ou Chen ^a   Huang, Ka Te ^a   Zhang, Xiao Hua ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

ABCG2; Colorectal cancer; Metastasis

Indexed keywords

EID: 78650695966     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Allikmets R, Schriml LM, Hutchinson A, et al (1998). A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res, 58, 5337-9.
2. An Y, Ongkeko WM (2009). ABCG2: The key to chemoresistance in cancer stem cells? Expert Opin Drug Metab Toxicol, 5, 1529-42.
3. Aye IL, Paxton JW, Evseenko DA, et al (2007). Expression, localisation and activity of ATP binding cassette (ABC) family of drug transporters in human amnion membranes. Placenta, 28, 868-7.
4. Candeil L, Gourdier I, Peyron D, et al (2004). ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases. Int J Cancer, 109, 848-54.
5. Ding XW, Wu JH, Jiang CP (2010). ABCG2: A potential marker of stem cells and novel target in stem cell and cancer therapy. Life Sci, 86, 631-7.
6. Doyle LA, Yang W, Abruzzo LV, et al (1998). A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A, 95, 15665-70.
7. Fletcher JI, Haber M, Henderson MJ, et al (2010). ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer, 10, 147-56.
8. Gupta N, Martin PM, Miyauchi Si, et al (2006). Down-regulation of BCRP/ABCG2 in colorectal and cervical cancer. Biochem Biophys Res Commun, 343, 571-7.
9. Haraguchi N, Utsunomiya T, Inoue H, et al (2006). Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells, 24, 506-13.
10. Hao XP, Willis JE, Pretlow TG, et al (2000). Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions. Cancer Res, 60, 18-21.
11. Hao XP, Pretlow TG, Rao JSo, et al (2001). Beta-catenin expression is altered in human colonic aberrant crypt foci. Cancer Res, 61, 8085-8.
12. Hu LL, Wang XX, Chen X, et al (2007). BCRP gene polymorphisms are associated with susceptibility and survival of diffuse large B-cell lymphoma. Carcinogenesis, 28, 1740-4.
13. Kalalinia F, Elahian F, Behravan J (2010). Potential role of cyclooxygenase-2 on the regulation of the drug efflux transporter ABCG2 in breast cancer cell lines. J Cancer Res Clin Oncol, 27.
14. Kawahara H, Noguchi K, Katayama K, et al (2010). Pharmacological interaction with sunitinib is abolished by a germ-line mutation (1291T>C) of BCRP/ABCG2 gene. Cancer Sci, 101, 1493-500.
15. Maliepaard M, Scheffer GL, Faneyte IF, et al (2001). Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res, 61, 3458-64.
16. Miyake K, Mickley L, Litman T, et al (1999). Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res, 59, 8-13.
17. Pollex EK, Anger G, Hutson J, et al (2010). Breast cancer resistance protein (BCRP)-mediated glyburide transport: Effect of the C421A/Q141K BCRP single-nucleotide polymorphism. Drug Metab Dispos, 38, 740-4.
18. Raaijmakers MH, de Grouw EP, Heuver LH, et al (2005). Impaired breast cancer resistance protein mediated drug transport in plasma cells in multiple myeloma. Leuk Res, 29, 1455-8.
19. Shigeta J, Katayama K, Mitsuhashi J, et al (2010). BCRP/ABCG2 confers anticancer drug resistance without covalent dimerization. Cancer Sci, 101, 1813-21.
20. Yoh K, Ishii G, Yokose T, et al (2004). Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer. Clin Cancer Res, 10, 1691-7.
21. Zen Y, Fujii T, Yoshikawa S, et al (2007). Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma. Am J Pathol, 170, 1750-62.
22. Zhou S, Schuetz JD, Bunting KD, et al (2001). The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med, 7, 1028-34.
23. Zheng X, Cui D, Xu S, Brabant G, et al (2010). Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells. Int J Oncol, 37, 307-15.